Parkinson Disease

The AJMC^® Parkinson Disease compendium is a comprehensive resource for clinical news and expert insights for progressive nervous system disorder, which affects movement and often includes tremors.

Latest News

Adaptive Deep Brain Stimulation Technology Receives FDA Approval for Parkinson Disease

By Giuliana Grossi

February 26th 2025

The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of Parkinson disease.

Air Pollution Linked to PD, With Mississippi-Ohio River Valley Region Most Affected

Air Pollution Linked to PD, With Some Parts of US More Affected Than Others

By AJMC Staff

February 24th 2023

PD Worsens QOL, Increases Depression in Men More Than Women in the Southeast

By Allison Inserro

February 17th 2023

Certain Patient Groups Continue to Be Underrepresented in PD Studies in the Netherlands

By Jaime Rosenberg

February 4th 2023

Creating a Metric to Determine Social Functioning in Parkinson Disease

By Allison Inserro

February 1st 2023

More News

March 5th 2019

Examining the Link Between Cerebral Small-Vessel Diseases and Motor Symptoms in Parkinson Disease

Wallace Stephens

Researchers discovered a strong correlation between cerebral small vessel diseases and motor symptoms in patients with Parkinson disease, according to a recent cross-sectional study.

February 6th 2019

Embracing Innovation in Healthcare to Transform Delivery of Care

Jaime Rosenberg

During a session at AcademyHealth National Health Policy Conference held February 4-5 in Washington, DC, healthcare stakeholders discussed 3 innovations that are changing the way we think about healthcare: social determinants of health, digital health, and data.

January 29th 2019

What We're Reading: Right-to-Try Law Frustrations; Microbiome Links Explored; Measles Consequences

AJMC Staff

The man for whom the right-to-try law is named has been unable to get treatment; neuroscientists who were once skeptics are now being persuaded by new studies that have turned up fascinating links between the microbiome and the brain; public health officials are worried it could take months to contain the measles outbreak due to a lower-than-normal vaccination rate in Clark County, Washington, the epicenter of the crisis.

October 28th 2018

Ten Drug Combinations That Show the Risks of Psychiatric Polypharmacy

Allison Inserro

Using multiple drugs to treat a single condition is growing, said Paul Zarkowski, MD, a clinical assistant professor at Harborview Medical Center and psychiatrist in Seattle, Washington, at Psych Congress 2018. But how much do we know about how well they work?

September 12th 2018

New Research Finds Link Between ADHD and Parkinson Disease

Kelly Davio

Researchers from the University of Utah explain that patients with attention-deficit/hyperactivity disorder (ADHD) were more than twice as likely to develop early-onset Parkinson disease or a related basal ganglia and cerebellum disease than peers who do not have ADHD. Among patients with more severe disease who are prescribed stimulant medications to control their ADHD, the risk was 6- to 8-fold higher.

September 5th 2018

In the Effort to Diversify Clinical Trials, Trust, Access, and Education Play Crucial Roles

Kelly Davio

While funders and researchers have long held that clinical trials should enroll more diverse patients to better reflect the populations in which approved drugs will eventually be used, patient populations enrolled in clinical trials remain largely homogenous.

July 16th 2018

Forgotten Patients: ACO Attribution Omits Those With Low Service Use and the Dying

Mariétou H. Ouayogodé, PhD Ellen Meara, PhD Chiang-Hua Chang, PhD Stephanie R. Raymond, BA Julie P.W. Bynum, MD, MPH Valerie A. Lewis, PhD Carrie H. Colla, PhD

This article compares clinical and utilization profiles of Medicare patients who are attributed to provider groups with those of patients unattributed to any provider group in accountable care organization models.

February 1st 2018

FDA Approved a Record Number of Personalized Medicines in 2017

Kelly Davio

One in every 4 drugs approved by the FDA over the past 4 years was a personalized medicine, and the agency approved a record-breaking 16 personalized therapies in the past year, according to a new report from the multi-stakeholder group the Personalized Medicine Coalition.

January 19th 2018

Wearable Biosensors Have No Significant Impact on Clinical Outcomes

Kaitlynn Ely

Analysis of randomized controlled trials finds there is not enough proof that wearable biosensors actually improve patient outcomes, such as weight and blood pressure, according to a study by Cedars-Sinai investigators published in npj Digital Medicine.

December 17th 2017

Researchers Discover Genetic Profile Unique to Dementia With Lewy Bodies

Allison Inserro

In a discovery that could potentially pave the way for more targeted treatments, researchers announced that dementia with Lewy bodies (DLB) has a unique genetic profile, separate from those of Alzheimer disease or Parkinson disease (PD). Researchers also found that DLB has heritability traits similar to PD.

July 16th 2017

CDC Finds Higher ALS, Parkinson Disease Mortality in Those With White-Collar Occupations

Alison Rodriguez

The progressive neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and Parkinson disease share the risk factors of increased age and male sex, but new research indicates there is also an association between a patientâ€™s occupation and the mortality rate from these diseases.

...

8 9 10 11 12